Kolun Pharmaceutical: net profit in the first quarter was 584 million yuan, a year-on-year decrease of 43.07%

Kelin Pharmaceuticals disclosed its first quarter report on the evening of April 29th, showing that the company achieved operating income of 4.39 billion yuan in the first quarter of 2025, a year-on-year decrease of 29.42%; net profit was 584 million yuan, a year-on-year decrease of 43.07%, mainly due to the decrease in operating income and investment income.